Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  iobenguane I 131
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-12 of 12 for your search:
Start Over
Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma
Phase: Phase III
Type: Diagnostic
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: MBG308, NCT00126412
Phase 1-2 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MIP-IB12, NCT00458952
CHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II Study
Phase: Phase II
Type: Treatment
Status: Closed
Age: Child
Sponsor: Other
Protocol IDs: NCRR-M01RR00240-1748, NCT00013806
131MIBG to Treat Malignant Pheochromocytoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: NICHD
Protocol IDs: 020032, 02-CH-0032, NCT00028106
N2001-02: I-Metaiodobenzylguanidine (MIBG) With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 1 to 29
Sponsor: NCI, Other
Protocol IDs: CDR0000450148, P01CA081403, N2001-02, NANT-2001-02, NCT00253435
N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma
Phase: Phase I
Type: Treatment
Status: Completed
Age: 1 to 21 (1 to 20 at diagnosis)
Sponsor: NCI, Other
Protocol IDs: CDR0000067966, P01CA081403, N99-01, NANT-99-01, CHLA-LA-NANT-99-01, NCI-V00-1592, NCT00005978
N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation
Phase: Phase I
Type: Treatment
Status: Completed
Age: 1 to 30
Sponsor: NCI, Other
Protocol IDs: CDR0000363631, P01CA081403, N2000-01, NANT-2000-01, NCT00083135
N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma
Phase: Phase I
Type: Treatment
Status: Completed
Age: 1 to 30
Sponsor: NCI, Other
Protocol IDs: CDR0000558042, P01CA081403, N2004-06, NANT-Draximage-2007-01, NANT-2004-06, NANT N2004-06, NANT-N04-06, NCT00509353
N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 2 to 30
Sponsor: NCI, Other
Protocol IDs: CDR0000659059, P01CA081403, N2007-03, NANT-N2007-03, NCT01019850
High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed Neuroblastoma
Phase: No phase specified
Type: Treatment
Status: Completed
Age: 1 to 30
Sponsor: Other
Protocol IDs: MIBG Irino, NCT01313936
Start Over